2022 Program – Day 2

Dr. Mouza Mohd Al Ameri

Consultant Physician, Oncology – Breast Care Center (Dep) | United Arab Emirates

Mouza Al Ameri is a breast onco-plastic surgeon and assistant professor of surgery in UAE University and Tawam Hospital. She is passionate about breast cancer research, empowering breast cancer survivors and disseminate breast cancer awareness among society members.

Dr. Stephen Grobmyer

Institute Chair of the Oncology | United Arab Emirates

"Dr. Stephen R. Grobmyer, MD, is the Institute Chair of the Oncology Institute at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Grobmyer was Professor of Surgery, Section Head of Breast Surgery and Co-Director of the Cleveland Clinic Comprehensive Breast Cancer Program at Cleveland Clinic Main Campus in Cleveland, Ohio. Dr. Grobmyer received his medical degree from the University of Texas Southwestern Medical School in Dallas, Texas and completed his residency in General Surgery at New York Hospital-Cornell Medical Center in New York. He completed a fellowship in Surgical Oncology at Memorial Sloan Kettering in 2004. Dr. Grobmyer™s innovative clinical care and research focuses on developing new approaches to prevent, diagnose and treat breast cancer. He has published over 170 peer-reviewed manuscripts, twenty book chapters and edited a textbook on innovative cancer therapies. Additionally, he has given over one hundred invited lectures nationally and internationally. "

Dr. Sibylle Loibl

Chief Executive Officer | Germany

"Prof. Dr. Sibylle Loibl is Chair of the German Breast Group and the Chief Executive Officer of the GBG Forschungs GmbH. Prof. Dr. Loibl is an associate professor of obstetrics and gynaecology at the Goethe University of Frankfurt. She gained a doctorate at the Ruprecht Karl University of Heidelberg and trained as a consultant in gynaecology and obstetrics at the women’s clinics of the university hospitals in Heidelberg and Frankfurt am Main. She devotes most of her time to clinical research within the German Breast Group and clinical work at the Centre for Haematology and Oncology, Bethanien in Frankfurt. Prof. Dr. Loibl has gained international renommée for her research in neoadjuvant breast cancer, breast cancer during pregnancy and breast cancer in young women. She established the Translational Research Group within the German Breast Group and has headed numerous research projects. In addition, Prof. Dr. Loibl has been involved in conducting and managing a significant number of national and international, practice-changing clinical trials. Prof. Dr. Loibl is author of more than 400 original and peer-reviewed articles and scientific papers; she has written numerous books and book chapters. She is an active member of many important national and international organizations, such as ASCO, ESMO, DKG and the AGO. She is involved in national and international guidelines for breast cancer, amongst them those for ESMO and ASCO. She was the first Co-Chair of the ESMO Breast Conference in Berlin and is an active faculty member of many international (ASCO, ESMO, SABCS) conferences."

Dr. Aydah Al Awadhi

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Aydah Al Awadhi is a Consultant Physician, Oncology Clinic at Tawam Hospital

Dr. Zulfaqqar Ali

Oncologist/Haematologist | United Arab Emirates

Dr. JaffarAli trained at Columbia University/Roosevelt Hospital, New York and gained his Fellowship in Haematology and Oncology from New York Medical college, St. Vincent's Hospital. He is triple American board certified in Internal Medicine, Haematology and Medical Oncology. He practised in the USA as an Oncologist/Haematologist for more than 15 years prior to moving back to the UAE and has particular interests in breast cancer, cutting edge oncology treatments such as immunotherapy and genetic predisposition to cancers. He has been involved in clinical research in multiple cancers and has published and presented at the American Society of Clinical Oncology. He is a member of the American Society of Oncology.

Dr. Abdulla Alhasso

Consultant Clinical Oncologist | United Arab Emirates

Dr Abdulla Alhasso has joined the Beatson Oncology Centre as a Clinical Oncologist with a special interest in Breast cancer and Urological malignancies. He is actively involved in the provision of clinical services in Clyde area as well as South Glasgow. This involves direct clinical care through outpatient clinics including follow up, new patients and chemotherapy clinics. He is also involved in the medical training and supervision for the junior Oncology team and take an active role in medical research and clinical trials.

Dr. Carlos Barrios

Director and Principal Investigator | Brazil

Dr. Carlos Barrios is the Director and Principal Investigator of the Oncology Research Center at Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul since 1996, where he has participated in more than 300 clinical research trials during the past 15 years. He is Director of Clinical Research and Oncologist of the Oncoclínicas Group in Porto Alegre. He is Adjunct Assistant Professor of the William Harrington Latin American Program of the University of Miami School of Medicine. He has a strong interest in the development of international research collaboration and implementation of cooperative research infrastructures in Latin America.

Dr. Emad Dawoud

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt. Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Dr. Mohanad Diab

Consultant Medical Oncology | United Arab Emirates

Dr. Mohanad Diab is an established and highly skilled Consultant Medical Oncologist with over 12 years of experience in the field of Oncology. He pursued his MD in 2004 from Karolinska University, Sweden. He obtained his Certification in Bone Marrow Transplantation in 2008 from Oncology Hospital, Radiumhemmet. Dr. Diab spent the first half of his career in the hospitals of the West Gotland Region, Sweden, as a Consultant Medical Oncologist. In 2014, he relocated to UAE and served eight years as the Head of the Oncology Department in one of the leading private hospitals in Abu Dhabi before joining Burjeel Hospital, Abu Dhabi. He is well regarded for his active involvement in setting up a world-class oncology clinic and multi-disciplinary tumor board. His expertise is treating distinctive cancers through chemotherapy, targeted therapy, and immunotherapy. The conditions include brain cancer, oligodendroglioma, pancreatic cancer, colorectal cancer, meningioma, prostate cancer, mixed gliomas, lung cancer, ependymoma, metastatic cancer, oral cancer, primitive neuroectodermal tumor, breast cancer, cervical and ovarian cancer. He is an active contributor to the research & studies dedicated to the field of oncology and tumor diagnosis.

Dr. Stephen Grobmyer

Institute Chair of the Oncology | United Arab Emirates

"Dr. Stephen R. Grobmyer, MD, is the Institute Chair of the Oncology Institute at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Grobmyer was Professor of Surgery, Section Head of Breast Surgery and Co-Director of the Cleveland Clinic Comprehensive Breast Cancer Program at Cleveland Clinic Main Campus in Cleveland, Ohio. Dr. Grobmyer received his medical degree from the University of Texas Southwestern Medical School in Dallas, Texas and completed his residency in General Surgery at New York Hospital-Cornell Medical Center in New York. He completed a fellowship in Surgical Oncology at Memorial Sloan Kettering in 2004. Dr. Grobmyer™s innovative clinical care and research focuses on developing new approaches to prevent, diagnose and treat breast cancer. He has published over 170 peer-reviewed manuscripts, twenty book chapters and edited a textbook on innovative cancer therapies. Additionally, he has given over one hundred invited lectures nationally and internationally. "

Dr. Abdulla Alhasso

Consultant Clinical Oncologist | United Arab Emirates

Dr Abdulla Alhasso has joined the Beatson Oncology Centre as a Clinical Oncologist with a special interest in Breast cancer and Urological malignancies. He is actively involved in the provision of clinical services in Clyde area as well as South Glasgow. This involves direct clinical care through outpatient clinics including follow up, new patients and chemotherapy clinics. He is also involved in the medical training and supervision for the junior Oncology team and take an active role in medical research and clinical trials.

Dr. Zulfaqqar Ali

Oncologist/Haematologist | United Arab Emirates

Dr. JaffarAli trained at Columbia University/Roosevelt Hospital, New York and gained his Fellowship in Haematology and Oncology from New York Medical college, St. Vincent's Hospital. He is triple American board certified in Internal Medicine, Haematology and Medical Oncology. He practised in the USA as an Oncologist/Haematologist for more than 15 years prior to moving back to the UAE and has particular interests in breast cancer, cutting edge oncology treatments such as immunotherapy and genetic predisposition to cancers. He has been involved in clinical research in multiple cancers and has published and presented at the American Society of Clinical Oncology. He is a member of the American Society of Oncology.

Dr. Sibylle Loibl

Chief Executive Officer | Germany

"Prof. Dr. Sibylle Loibl is Chair of the German Breast Group and the Chief Executive Officer of the GBG Forschungs GmbH. Prof. Dr. Loibl is an associate professor of obstetrics and gynaecology at the Goethe University of Frankfurt. She gained a doctorate at the Ruprecht Karl University of Heidelberg and trained as a consultant in gynaecology and obstetrics at the women’s clinics of the university hospitals in Heidelberg and Frankfurt am Main. She devotes most of her time to clinical research within the German Breast Group and clinical work at the Centre for Haematology and Oncology, Bethanien in Frankfurt. Prof. Dr. Loibl has gained international renommée for her research in neoadjuvant breast cancer, breast cancer during pregnancy and breast cancer in young women. She established the Translational Research Group within the German Breast Group and has headed numerous research projects. In addition, Prof. Dr. Loibl has been involved in conducting and managing a significant number of national and international, practice-changing clinical trials. Prof. Dr. Loibl is author of more than 400 original and peer-reviewed articles and scientific papers; she has written numerous books and book chapters. She is an active member of many important national and international organizations, such as ASCO, ESMO, DKG and the AGO. She is involved in national and international guidelines for breast cancer, amongst them those for ESMO and ASCO. She was the first Co-Chair of the ESMO Breast Conference in Berlin and is an active faculty member of many international (ASCO, ESMO, SABCS) conferences."

Dr. Carlos Barrios

Director and Principal Investigator | Brazil

Dr. Carlos Barrios is the Director and Principal Investigator of the Oncology Research Center at Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul since 1996, where he has participated in more than 300 clinical research trials during the past 15 years. He is Director of Clinical Research and Oncologist of the Oncoclínicas Group in Porto Alegre. He is Adjunct Assistant Professor of the William Harrington Latin American Program of the University of Miami School of Medicine. He has a strong interest in the development of international research collaboration and implementation of cooperative research infrastructures in Latin America.

Dr. Mouza Mohd Al Ameri

Consultant Physician, Oncology – Breast Care Center (Dep) | United Arab Emirates

Mouza Al Ameri is a breast onco-plastic surgeon and assistant professor of surgery in UAE University and Tawam Hospital. She is passionate about breast cancer research, empowering breast cancer survivors and disseminate breast cancer awareness among society members.

Dr. Nouri Bennini

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr.Nouri Bennini is a Consultant Physician, Oncology Clinic at Tawam Hospital.

Prof. Michail Ignatiadis

Senior Attending Physician | Belgium

"Michail Ignatiadis, MD PhD is senior attending physician at the Medical Oncology Department, Jules Bordet Institute (IJB) and associate professor at the Université Libre de Bruxelles, Belgium. Since January 2021, he is the chair of the breast cancer group of the EORTC. He is also leading the Academic Trials Promoting Team (ATPT) and he is member of the Executive and Research Boards of IJB since October 2016. He participates in developing the IJB research strategy. He works with his team and members of the Executive and Research Boards to promote high-quality, innovative, academic research at the institutional level. From June 2018 to January 2021, he served in the Board of Directors of the EORTC as the chair of the clinical research division. He has been involved in many investigator-initiated trials (IITs) sponsored by IJB at different stages of their development. He has been member of the Independent Data Monitoring Committees for international trials and study chair of several IITs. He served as IJB principal investigator for many industry sponsored trials. Currently, he is the study chair of the Alexandra/Impassion030 registration trial. He is particularly interested in drug and biomarker development in breast cancer. His work in the field of blood-based biomarkers is widely recognised at the international level. He has published more than 100 articles in peer reviewed journals including several papers in high impact factor journals such as Journal of Clinical Oncology, Nature Reviews Clinical Oncology, JAMA Oncology, Journal of National Cancer Institute, Lancet Oncology as well as several book chapters; he is editor of a book on minimal residual disease. He has served as reviewer for several national and international organisations including the French National Cancer Institute (INCA), the Technology Foundation STW in the Netherlands, the Marie-Curie Fellowships, the European Research Council (ERC) and the Innovative Medicines Initiative (IMI). He has served as Chair or Co-Chair of symposia in high visibility international conferences, organised by ESMO, ECCO and ASCO. He has served as faculty in the prestigious workshop ‘Methods in Clinical Cancer Research’ every year from 2014 until 2019. He has obtained independent research funding over the last 6 years."

Dr. Anwar Al Nouri

Oncologist | Kuwait

Dr. Anwar Al Nouri is an oncologist at Kuwait Cancer Control Centre

Dr. Carlos Barrios

Director and Principal Investigator | Brazil

Dr. Carlos Barrios is the Director and Principal Investigator of the Oncology Research Center at Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul since 1996, where he has participated in more than 300 clinical research trials during the past 15 years. He is Director of Clinical Research and Oncologist of the Oncoclínicas Group in Porto Alegre. He is Adjunct Assistant Professor of the William Harrington Latin American Program of the University of Miami School of Medicine. He has a strong interest in the development of international research collaboration and implementation of cooperative research infrastructures in Latin America.

Dr. Hassan Ghazal

Consultant Medical Oncologist & Consultant Clinical Hematologist | United Arab Emirates

"Dr Hassan Ghazal is an American board-certified Consultant Medical Oncologist and a Consultant Clinical hematologist offering more than 3 decades of clinical experience. Dr Hassan Ghazal, after doing his basic medical education in American University of Beirut, moved to US for his residency program in Internal Medicine at Sinai Hospital of Baltimore, MD. In 1992, completing the residency program, Dr Hassan Ghazal joined in George Washington university Medical Center for his fellowship in Medical Oncology and completed the same in 1995. He continued in George Washington University Medical Center for another 2 years and obtained his senior fellowship in bone marrow transplantation in the year 1997. He got his US board certification in Internal Medicine, Medical Oncology and in Hematology in the year 1992, 1995,1996 respectively. Except his association with CMC for the preceding 3 years, all his clinical practices were in US in various capacities including Director, Kentucky Cancer Clinic and Staff Oncologist/ Hematologist at Hazard Appalachian Regional Medical Center. Dr Hassan Ghazal is a member of various clinical societies such as American College of Physicians, American Society of Haematology, American Society of Clinical Oncology, European Society of Medical Oncology etc. Dr Hassan Ghazal has got many publications and abstracts in his credit, in peer reviewed journals, and there are many international recognitions and accolades in his name. He has been involved in numerous clinical trials, nearly 100, in the US, serving as Principal Investigator, for over 25 years, and enrolled hundreds of patients in these trials."

Dr. Aladdin Marraoui

Consultant and Chief of Medical Oncology | United Arab Emirates

Dr. Maarraoui is Consultant and Chief of Hematology/Oncology at Gulf International Cancer Center in Abu Dhabi and Clinical Professor at Gulf Medical University, UAE. He previously served as Chief of Hematology/Oncology at Mafraq Hospital for 14 years. He graduated from Faculty of Medicine at Aleppo University/Syria. He did his Internal Medicine residency at Christ Hospital and Medical Center in Chicago, and his Hematology/Oncology fellowship at the University of Colorado Health Science Center in Denver, Colorado. He is American Board Certified and recertified in Internal medicine in 1992, 2002 and 2012, in Medical Oncology in 1999,2009 and 2019 and in Hematology in 1999, 2009 and 2019. Dr. Maarraoui authored and co-authored several abstracts and articles on Breast Cancer, Colon Cancer, Thyroid Cancer, lung cancer and Lymphoma focusing on these diseases in UAE.

Prof. Michail Ignatiadis

Senior Attending Physician | Belgium

"Michail Ignatiadis, MD PhD is senior attending physician at the Medical Oncology Department, Jules Bordet Institute (IJB) and associate professor at the Université Libre de Bruxelles, Belgium. Since January 2021, he is the chair of the breast cancer group of the EORTC. He is also leading the Academic Trials Promoting Team (ATPT) and he is member of the Executive and Research Boards of IJB since October 2016. He participates in developing the IJB research strategy. He works with his team and members of the Executive and Research Boards to promote high-quality, innovative, academic research at the institutional level. From June 2018 to January 2021, he served in the Board of Directors of the EORTC as the chair of the clinical research division. He has been involved in many investigator-initiated trials (IITs) sponsored by IJB at different stages of their development. He has been member of the Independent Data Monitoring Committees for international trials and study chair of several IITs. He served as IJB principal investigator for many industry sponsored trials. Currently, he is the study chair of the Alexandra/Impassion030 registration trial. He is particularly interested in drug and biomarker development in breast cancer. His work in the field of blood-based biomarkers is widely recognised at the international level. He has published more than 100 articles in peer reviewed journals including several papers in high impact factor journals such as Journal of Clinical Oncology, Nature Reviews Clinical Oncology, JAMA Oncology, Journal of National Cancer Institute, Lancet Oncology as well as several book chapters; he is editor of a book on minimal residual disease. He has served as reviewer for several national and international organisations including the French National Cancer Institute (INCA), the Technology Foundation STW in the Netherlands, the Marie-Curie Fellowships, the European Research Council (ERC) and the Innovative Medicines Initiative (IMI). He has served as Chair or Co-Chair of symposia in high visibility international conferences, organised by ESMO, ECCO and ASCO. He has served as faculty in the prestigious workshop ‘Methods in Clinical Cancer Research’ every year from 2014 until 2019. He has obtained independent research funding over the last 6 years."

Dr. Anwar Al Nouri

Oncologist | Kuwait

Dr. Anwar Al Nouri is an oncologist at Kuwait Cancer Control Centre

Dr. Carlos Barrios

Director and Principal Investigator | Brazil

Dr. Carlos Barrios is the Director and Principal Investigator of the Oncology Research Center at Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul since 1996, where he has participated in more than 300 clinical research trials during the past 15 years. He is Director of Clinical Research and Oncologist of the Oncoclínicas Group in Porto Alegre. He is Adjunct Assistant Professor of the William Harrington Latin American Program of the University of Miami School of Medicine. He has a strong interest in the development of international research collaboration and implementation of cooperative research infrastructures in Latin America.

Dr. Meteb Foheidi

Medical Oncology Consultant | Saudi Arabia

Dr. Meteb Foheidi is a medical oncology consultant at Princess Noorah Oncology Center, National Guard Health Affairs, Jeddah, Asistant Professor & Medical Oncology Block Cordinator at King Saud Bin Abdulaziz University for Health and Science – Jeddah and Western Oncology Group Director, Saudi Oncology Society.

Dr. Aydah Al Awadhi

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Aydah Al Awadhi is a Consultant Physician, Oncology Clinic at Tawam Hospital

Dr. Diaeddine Trad

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Diaeddine Trad is a Consultant of Medical Oncology, at Tawam Hospital, in Al Ain, UAE. He is a member of the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is an investigator in several ongoing clinical trials. Dr. Trad is certified as a specialist in internal medicine, hematology and oncology by the Lebanese Ministry of Health. His research interests include; non-small cell lung adenocarcinoma and locally advanced breast cancer. Dr. Trad was a speaker in many international conferences and forums.

Prof. Michail Ignatiadis

Senior Attending Physician | Belgium

"Michail Ignatiadis, MD PhD is senior attending physician at the Medical Oncology Department, Jules Bordet Institute (IJB) and associate professor at the Université Libre de Bruxelles, Belgium. Since January 2021, he is the chair of the breast cancer group of the EORTC. He is also leading the Academic Trials Promoting Team (ATPT) and he is member of the Executive and Research Boards of IJB since October 2016. He participates in developing the IJB research strategy. He works with his team and members of the Executive and Research Boards to promote high-quality, innovative, academic research at the institutional level. From June 2018 to January 2021, he served in the Board of Directors of the EORTC as the chair of the clinical research division. He has been involved in many investigator-initiated trials (IITs) sponsored by IJB at different stages of their development. He has been member of the Independent Data Monitoring Committees for international trials and study chair of several IITs. He served as IJB principal investigator for many industry sponsored trials. Currently, he is the study chair of the Alexandra/Impassion030 registration trial. He is particularly interested in drug and biomarker development in breast cancer. His work in the field of blood-based biomarkers is widely recognised at the international level. He has published more than 100 articles in peer reviewed journals including several papers in high impact factor journals such as Journal of Clinical Oncology, Nature Reviews Clinical Oncology, JAMA Oncology, Journal of National Cancer Institute, Lancet Oncology as well as several book chapters; he is editor of a book on minimal residual disease. He has served as reviewer for several national and international organisations including the French National Cancer Institute (INCA), the Technology Foundation STW in the Netherlands, the Marie-Curie Fellowships, the European Research Council (ERC) and the Innovative Medicines Initiative (IMI). He has served as Chair or Co-Chair of symposia in high visibility international conferences, organised by ESMO, ECCO and ASCO. He has served as faculty in the prestigious workshop ‘Methods in Clinical Cancer Research’ every year from 2014 until 2019. He has obtained independent research funding over the last 6 years."

Dr. Faisal Al Terkait

Medical Oncologist | Kuwait

"Medical oncologist in Kuwait cancer control center from 2012, Head of breast unit from 2017 to 2021, inaugurated the first medical oncology departments outside kccc in Kuwait. Currently Head of Medical oncology department at Jaber al-Ahmad hospital in Kuwait. MRCP UK. MBBS UK. CCST ONCOLOGY UK "

Dr. Meteb Foheidi

Medical Oncology Consultant | Saudi Arabia

Dr. Meteb Foheidi is a medical oncology consultant at Princess Noorah Oncology Center, National Guard Health Affairs, Jeddah, Asistant Professor & Medical Oncology Block Cordinator at King Saud Bin Abdulaziz University for Health and Science – Jeddah and Western Oncology Group Director, Saudi Oncology Society.

Prof. Michail Ignatiadis

Senior Attending Physician | Belgium

"Michail Ignatiadis, MD PhD is senior attending physician at the Medical Oncology Department, Jules Bordet Institute (IJB) and associate professor at the Université Libre de Bruxelles, Belgium. Since January 2021, he is the chair of the breast cancer group of the EORTC. He is also leading the Academic Trials Promoting Team (ATPT) and he is member of the Executive and Research Boards of IJB since October 2016. He participates in developing the IJB research strategy. He works with his team and members of the Executive and Research Boards to promote high-quality, innovative, academic research at the institutional level. From June 2018 to January 2021, he served in the Board of Directors of the EORTC as the chair of the clinical research division. He has been involved in many investigator-initiated trials (IITs) sponsored by IJB at different stages of their development. He has been member of the Independent Data Monitoring Committees for international trials and study chair of several IITs. He served as IJB principal investigator for many industry sponsored trials. Currently, he is the study chair of the Alexandra/Impassion030 registration trial. He is particularly interested in drug and biomarker development in breast cancer. His work in the field of blood-based biomarkers is widely recognised at the international level. He has published more than 100 articles in peer reviewed journals including several papers in high impact factor journals such as Journal of Clinical Oncology, Nature Reviews Clinical Oncology, JAMA Oncology, Journal of National Cancer Institute, Lancet Oncology as well as several book chapters; he is editor of a book on minimal residual disease. He has served as reviewer for several national and international organisations including the French National Cancer Institute (INCA), the Technology Foundation STW in the Netherlands, the Marie-Curie Fellowships, the European Research Council (ERC) and the Innovative Medicines Initiative (IMI). He has served as Chair or Co-Chair of symposia in high visibility international conferences, organised by ESMO, ECCO and ASCO. He has served as faculty in the prestigious workshop ‘Methods in Clinical Cancer Research’ every year from 2014 until 2019. He has obtained independent research funding over the last 6 years."

Dr. Aydah Al Awadhi

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Aydah Al Awadhi is a Consultant Physician, Oncology Clinic at Tawam Hospital

Dr. Diaeddine Trad

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Diaeddine Trad is a Consultant of Medical Oncology, at Tawam Hospital, in Al Ain, UAE. He is a member of the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is an investigator in several ongoing clinical trials. Dr. Trad is certified as a specialist in internal medicine, hematology and oncology by the Lebanese Ministry of Health. His research interests include; non-small cell lung adenocarcinoma and locally advanced breast cancer. Dr. Trad was a speaker in many international conferences and forums.

Dr. Norberto Santana

Chair of Thoracic Surgery | United Arab Emirates

Dr. Norberto is an experienced surgeon with a strong background in minimally invasive surgery, lung transplantation, hospital management, team leader, education, and translational research. He has recently joined SSMC-Mayo Clinic in Abu Dhabi as Chair of Thoracic Surgery. Previously, he was the Head of Thoracic Surgery and Lung Transplantation at one of the most prestigious hospitals in the Middle East, King Faisal Specialist Hospital & Research Center, ranked 76 worldwide. Here, he has set for the first time in the Kingdom of Saudi Arabia and the Middle East, the uniportal video-assisted thoracic surgery (VATS) program for lung resections, mediastinum, foregut, and pleural diseases, the uniportal VATS lung anatomical segmentectomy program in patients with lung cancer or centrally located lung metastasis to prevent the lobectomy, uniportal VATS decortication program to avoid the thoracotomy in patients with empyema, and the robotic thoracic surgery (RATS) program together with other novel programs such as: VATS cytoreductive surgery plus unidirectional hyperthermic intrathoracic chemotherapy (HITHOC) for patients with malignant pleural diseases (mesothelioma, thymoma, etc.), the introduction of ECMO and CBP for major airway and lung tumor resections, endoscopic closure of bronchopleural fistula, 3D reconstruction for personalized surgical treatment through the planning of lung sparing surgery, minimally invasive esophagectomy and chest wall tumors resection, periareolar biportal sympathetic chain clipping for patients with severe hyperhidrosis, submammary chest wall tumor resection and reconstruction and a VATS training program for fellows and residents.

Prof. Abdul Rahman Jazieh

Director of Innovations and Research and Director of International Program | USA

"Director of Innovations and Research and Director of International Program at Cincinnati Cancer Advisors, Cincinnati, OH, USA. Editor in Chief, Global Journal on Quality and Safety in Healthcare. Former Chairman and Professor, Department of Oncology and a Professor at King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. Former Professor and Chief of Hematology Oncology Division at University of Cincinnati. Founded the MENA-NCCN Collaborating Center (KSA) and the Association of VA Hematology Oncology (www.avaho.org) (USA). Specialized in hematology, and oncology with master’s Degree in public health in health education and communication. He published more than 100 articles, books, and book chapters. Dr. Jazieh won multiple honors including Proclamation to the City of Cincinnati, naming a day in the City as Dr. Abdul Rahman Jazieh Day in 2006 and Special Recognition from NCCN as Global Partner in Cancer Care 2018. "

Dr. Tim Benepal

Consultant Medical Oncologist | United Kingdom

Dr. Tim Benepal is a BSc, MB BS, FRCP, PhD, Consultant Medical Oncologist and Honorary Senior Lecturer at St Georges University Hospitals NHS Trust, London, UK

Dr. Emad Dawoud

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt. Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Dr. Maroun Khoury

Consultant Oncologist/ Hematologist | United Arab Emirates

Assistant Professor Doctor Maroun El Khoury Consultant Oncologist/ Hematologist at American Hospital in Dubai 9/2010-Present. Mayo Clinic Network (Jci Accredited), Director Of Cancer Care Center, President of Medical Staff: 2018-2020. Chairperson Scientific Committee, Emirates Oncology Society: 2018-2020 .7/2006-8/2010: Private Practice In The Us/Iowa: Medical Director Of Oncology And Hematology Services And Chief Of Medicine At Great River Health System .7/2006-2010: Hospice Medical Co-Director .Epec (Education In Palliative And End-Of-Life Care) Trainer.

Dr. Aref Chehal

Adjunct Clinical Associate Professor of Medicine | United Arab Emirates

Dr. Chehal is an Adjunct Clinical Associate Professor of Medicine, Gulf Medical University (GMU), Ajman, UAE Dr. Chehal is an Adjunct Clinical Associate Professor of Medicine, Khalifa University (KU), Abu Dhabi, UAE Dr. Chehal graduated from the college of Medicine at Baghdad University/Iraq (MBChB) in 1996. He did his Internal Medicine residency at Makassed General Hospital (Affiliated with American University of Beirut), Lebanon, between 1997 and 2000. He did his Hematology/Oncology fellowship at the American University of Beirut (AUBMC), Lebanon, between 2000 and 2003 (Lebanese Board). He obtained Fellowship of the American College of Physician (FACP) in 2013. He obtained the European Certification of Medical Oncology (ECMO) in 2009 and Re-certification in 2014 and 2021. Dr. Chehal is a member of many national and international societies including ASCO, ESMO, EHA,….. He had an important role in Tumor registry in Lebanon in 2002. Dr. Chehal acted as chairperson, moderator, advisor, and member of scientific committee in many local and international congresses. Dr. Chehal has 27 published articles in peer reviewed international journals; he is the first author on 9 of them, in addition to 31 abstracts. He joined Mafraq hospital From May 2006 until December 2019. He served as head of Hematology Oncology division at Mafraq Hospital from December 2018 till December 2019 His main interests are Lung cancer, Breast Cancer, GI malignancies and Lymphoma.

Dr. Norberto Santana

Chair of Thoracic Surgery | United Arab Emirates

Dr. Norberto is an experienced surgeon with a strong background in minimally invasive surgery, lung transplantation, hospital management, team leader, education, and translational research. He has recently joined SSMC-Mayo Clinic in Abu Dhabi as Chair of Thoracic Surgery. Previously, he was the Head of Thoracic Surgery and Lung Transplantation at one of the most prestigious hospitals in the Middle East, King Faisal Specialist Hospital & Research Center, ranked 76 worldwide. Here, he has set for the first time in the Kingdom of Saudi Arabia and the Middle East, the uniportal video-assisted thoracic surgery (VATS) program for lung resections, mediastinum, foregut, and pleural diseases, the uniportal VATS lung anatomical segmentectomy program in patients with lung cancer or centrally located lung metastasis to prevent the lobectomy, uniportal VATS decortication program to avoid the thoracotomy in patients with empyema, and the robotic thoracic surgery (RATS) program together with other novel programs such as: VATS cytoreductive surgery plus unidirectional hyperthermic intrathoracic chemotherapy (HITHOC) for patients with malignant pleural diseases (mesothelioma, thymoma, etc.), the introduction of ECMO and CBP for major airway and lung tumor resections, endoscopic closure of bronchopleural fistula, 3D reconstruction for personalized surgical treatment through the planning of lung sparing surgery, minimally invasive esophagectomy and chest wall tumors resection, periareolar biportal sympathetic chain clipping for patients with severe hyperhidrosis, submammary chest wall tumor resection and reconstruction and a VATS training program for fellows and residents.

Prof. Abdul Rahman Jazieh

Director of Innovations and Research and Director of International Program | USA

"Director of Innovations and Research and Director of International Program at Cincinnati Cancer Advisors, Cincinnati, OH, USA. Editor in Chief, Global Journal on Quality and Safety in Healthcare. Former Chairman and Professor, Department of Oncology and a Professor at King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. Former Professor and Chief of Hematology Oncology Division at University of Cincinnati. Founded the MENA-NCCN Collaborating Center (KSA) and the Association of VA Hematology Oncology (www.avaho.org) (USA). Specialized in hematology, and oncology with master’s Degree in public health in health education and communication. He published more than 100 articles, books, and book chapters. Dr. Jazieh won multiple honors including Proclamation to the City of Cincinnati, naming a day in the City as Dr. Abdul Rahman Jazieh Day in 2006 and Special Recognition from NCCN as Global Partner in Cancer Care 2018. "

Dr. Tim Benepal

Consultant Medical Oncologist | United Kingdom

Dr. Tim Benepal is a BSc, MB BS, FRCP, PhD, Consultant Medical Oncologist and Honorary Senior Lecturer at St Georges University Hospitals NHS Trust, London, UK

Dr. Diaeddine Trad

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Diaeddine Trad is a Consultant of Medical Oncology, at Tawam Hospital, in Al Ain, UAE. He is a member of the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is an investigator in several ongoing clinical trials. Dr. Trad is certified as a specialist in internal medicine, hematology and oncology by the Lebanese Ministry of Health. His research interests include; non-small cell lung adenocarcinoma and locally advanced breast cancer. Dr. Trad was a speaker in many international conferences and forums.

Dr. Emad Dawoud

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt. Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Dr. Jehad Abdullah

Consultant infectious disease | United Arab Emirates

Dr. Jehad Abdalla, M.D. is an American board-certified in both Internal Medicine and Infectious Diseases, currently works as an Infectious Diseases consultant at Al Rahba hospital in Abu Dhabi, head of the infection control and prevention committee and chairperson of antibiotic stewardship program and at Al Rahba hospital. Dr. Abdalla has a special interest in Tuberculosis as well as HIV management.

Dr. Nouri Bennini

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr.Nouri Bennini is a Consultant Physician, Oncology Clinic at Tawam Hospital.

Dr. Fathi Azribi

Consultant Medical Oncologist | United Arab Emirates

Dr Fathi Azribi is a Consultant Medical Oncologist. He graduated from Tripoli University, Libya, then completed specialty training in Oncology in the UK and obtained a Certificate of Completion of Training in Medical Oncology. His main interest is in thoracic, breast, gynaecological and gastrointestinal malignancies, with expertise in treatment with chemotherapy, immunotherapy, hormonal, and targeted therapy. He published several papers and abstracts in peer reviewed journals. He also founded the first Medical Oncology Fellowship program in the UAE.

Dr. Johan F Vansteenkiste

Professor of Internal Medicine | Belgium

"Johan F. Vansteenkiste is a Professor of Internal Medicine in the Faculty of Medicine at the Catholic University of Leuven, Belgium, and Head of Clinic in the Respiratory Oncology Unit and its Clinical Trial Unit at the Leuven University Hospital, Belgium. Professor Vansteenkiste studied Medicine at the Catholic University of Leuven before becoming a Board Certified Pulmonologist-Oncologist. He had additional training in Respiratory Oncology at the European School of Oncology in Milan, Italy, and in Respiratory Endoscopy at the Laser entre in Marseille, France, before gaining his Ph.D. at the Catholic University of Leuven in 1996. Professor Vansteenkiste is an active member of different national and international societies such as IASLC, ASCO, ESMO, ERS, and others. He is a member of the Board of Directors of IASLC from 2009-to 2013 and a member of the ESMO Lung Educational Group and Guidelines Group. He was Secretary of the Thoracic Oncology Assembly of the ERS and a member of the ERS School Board from 2009-to 2012. He is the principal investigator or co-investigator in several clinical trials in the area of lung cancer. He is an Associate Editor at the Journal of Thoracic Oncology, a member of the editorial board of the Journal of Clinical Oncology and several other journals, and author or co-author of more than 200 peer-reviewed papers and book chapters on Respiratory Oncology."

Dr. Faraz Khan

Head Of Hematology Program | United Arab Emirates

Asst Prof Dr. Faraz Khan is a Consultant Hematologist and Medical Oncologist with over 15 years experience in treating cancer and various blood diseases. He completed his Internal Medicine, Hematology and Medical oncology training from the University of Connecticut, CT, USA and is triple board certified in Internal medicine, Hematology and Medical Oncology. He worked as a consultant Hematologist/Medical Oncologist at PEI Cancer Treatment Center, PE, Canada and directed the provincial hemophilia and bleeding disorder clinic.

Dr. Ignacio Gil-Bazo

Head of the Department of Oncology | Spain

"Prof. Gil-Bazo is the Head of the Department of Oncology and Scientific Director of the Valencian Institute of Oncology (IVO) in the city of Valencia, Spain. He has previously served as Chairman of the Department of Oncology at the University of Navarra, in Pamplona, Spain. In addition, he is Associate Professor of Medicine at the Department of Oncology at the University of Navarra School of Medicine and Director of the New Therapeutic Targets Laboratory of the Program in Solid Tumors at the Center for Applied Medical Research (CIMA). Prof. Gil-Bazo is a Medical Oncologist with expertise in Thoracic Oncology, Translational Research in Oncology and Clinical Investigation. The Valencian Institute of Oncology (IVO), an OECI accredited Cancer Center, is a nationally and internationally renowned institution, the largest and most prestigious private cancer center in Spain."

Prof. Abdul Rahman Jazieh

Director of Innovations and Research and Director of International Program | USA

"Director of Innovations and Research and Director of International Program at Cincinnati Cancer Advisors, Cincinnati, OH, USA. Editor in Chief, Global Journal on Quality and Safety in Healthcare. Former Chairman and Professor, Department of Oncology and a Professor at King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. Former Professor and Chief of Hematology Oncology Division at University of Cincinnati. Founded the MENA-NCCN Collaborating Center (KSA) and the Association of VA Hematology Oncology (www.avaho.org) (USA). Specialized in hematology, and oncology with master’s Degree in public health in health education and communication. He published more than 100 articles, books, and book chapters. Dr. Jazieh won multiple honors including Proclamation to the City of Cincinnati, naming a day in the City as Dr. Abdul Rahman Jazieh Day in 2006 and Special Recognition from NCCN as Global Partner in Cancer Care 2018. "

Dr. Ignacio Gil-Bazo

Head of the Department of Oncology | Spain

"Prof. Gil-Bazo is the Head of the Department of Oncology and Scientific Director of the Valencian Institute of Oncology (IVO) in the city of Valencia, Spain. He has previously served as Chairman of the Department of Oncology at the University of Navarra, in Pamplona, Spain. In addition, he is Associate Professor of Medicine at the Department of Oncology at the University of Navarra School of Medicine and Director of the New Therapeutic Targets Laboratory of the Program in Solid Tumors at the Center for Applied Medical Research (CIMA). Prof. Gil-Bazo is a Medical Oncologist with expertise in Thoracic Oncology, Translational Research in Oncology and Clinical Investigation. The Valencian Institute of Oncology (IVO), an OECI accredited Cancer Center, is a nationally and internationally renowned institution, the largest and most prestigious private cancer center in Spain."

Dr. Fathi Azribi

Consultant Medical Oncologist | United Arab Emirates

Dr Fathi Azribi is a Consultant Medical Oncologist. He graduated from Tripoli University, Libya, then completed specialty training in Oncology in the UK and obtained a Certificate of Completion of Training in Medical Oncology. His main interest is in thoracic, breast, gynaecological and gastrointestinal malignancies, with expertise in treatment with chemotherapy, immunotherapy, hormonal, and targeted therapy. He published several papers and abstracts in peer reviewed journals. He also founded the first Medical Oncology Fellowship program in the UAE.

Dr. Faraz Khan

Head Of Hematology Program | United Arab Emirates

Asst Prof Dr. Faraz Khan is a Consultant Hematologist and Medical Oncologist with over 15 years experience in treating cancer and various blood diseases. He completed his Internal Medicine, Hematology and Medical oncology training from the University of Connecticut, CT, USA and is triple board certified in Internal medicine, Hematology and Medical Oncology. He worked as a consultant Hematologist/Medical Oncologist at PEI Cancer Treatment Center, PE, Canada and directed the provincial hemophilia and bleeding disorder clinic.

Dr. Johan F Vansteenkiste

Professor of Internal Medicine | Belgium

"Johan F. Vansteenkiste is a Professor of Internal Medicine in the Faculty of Medicine at the Catholic University of Leuven, Belgium, and Head of Clinic in the Respiratory Oncology Unit and its Clinical Trial Unit at the Leuven University Hospital, Belgium. Professor Vansteenkiste studied Medicine at the Catholic University of Leuven before becoming a Board Certified Pulmonologist-Oncologist. He had additional training in Respiratory Oncology at the European School of Oncology in Milan, Italy, and in Respiratory Endoscopy at the Laser entre in Marseille, France, before gaining his Ph.D. at the Catholic University of Leuven in 1996. Professor Vansteenkiste is an active member of different national and international societies such as IASLC, ASCO, ESMO, ERS, and others. He is a member of the Board of Directors of IASLC from 2009-to 2013 and a member of the ESMO Lung Educational Group and Guidelines Group. He was Secretary of the Thoracic Oncology Assembly of the ERS and a member of the ERS School Board from 2009-to 2012. He is the principal investigator or co-investigator in several clinical trials in the area of lung cancer. He is an Associate Editor at the Journal of Thoracic Oncology, a member of the editorial board of the Journal of Clinical Oncology and several other journals, and author or co-author of more than 200 peer-reviewed papers and book chapters on Respiratory Oncology."

Dr. Omran El Koha

Consultant Radiation /Clinical Oncologist | United Arab Emirates

Dr. Omran is an experienced clinical oncologist with a demonstrated history of working in the medical and radiation oncology p . Skilled in Clinical Research, Medical Education, Strategic Planning. Strong education professional with a Master's Degree focused in Health research ethics

Dr. Diaeddine Trad

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Diaeddine Trad is a Consultant of Medical Oncology, at Tawam Hospital, in Al Ain, UAE. He is a member of the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is an investigator in several ongoing clinical trials. Dr. Trad is certified as a specialist in internal medicine, hematology and oncology by the Lebanese Ministry of Health. His research interests include; non-small cell lung adenocarcinoma and locally advanced breast cancer. Dr. Trad was a speaker in many international conferences and forums.

Dr. Arif Raza Alam

Chief of Hematology | United Arab Emirates

Chief of Hematology – Tawam Hospital

Prof. Mahmoud Marashi

Consultant Haematologist | United Arab Emirates

"Prof. Mahmoud Marashi joined Mediclinic City Hospital as Consultant Haematologist with over 30 years experience in haematology. He established the clinical haematology service in Dubai Health Authority which is involved in the management of both benign disorders (anaemias, bleeding disorders, thrombosis/thrombophilia) and malignant disorders (acute and chronic leukaemias, myeloma, myeloproliferative disorders, myelodysplastic syndrome). He runs both an undergraduate and postgraduate training in Haematology. Prof. Marashi did his undergraduate training in Andhra University, India. His haematology training was done in the UL at Heartlands Hospital, Birmingham, (formerly East Birmingham Hospital), The West Midlands Blood Transfusion Service, Edgbaston, Birmingham, The John Radcliffe Hospital and Chuchill Hospital in Oxford, UK. Prof. Marashi has been involved in medical education for over 20 years. He is a Professor of Medicine and Haematology and is the Head of the Academic Department of Medicine, Dubai Medical College / Dubai Health Authority. He is also an external examiner for the Royal College of Physicians of UK. *Independent Doctors (ID): Defined as individuals not employed by Mediclinic Middle East who are granted the privilege to treat patient at MCME facilities, in either inpatient or outpatient settings, as applicable."

Dr. Syed Mansoor Hasnain

Consultant Radiation Oncologist | United Arab Emirates

"Dr. Syed Mansoor Hasnain is working in Tawam Hospital, Alain, UAE as Consultant Radiation Oncologist. He joined Tawam Hospital in 2009. He initially trained as surgeon and did fellowship in surgery ,FRCS(Glasg) from Royal College Of Physicians and Surgeons Of Glasgow in 2000. In 2001 he started his career and specialist registrar Training in radiation Oncology under supervision of Faculty of Radiology, The Royal College Of Surgeons In Ireland in Saint Luke’s Hospital. He passed FRCR part 1 from Royal College of Radiologists, London U.K. He did fellowship in radiotherapy ‘FFR RCSI’ from Faculty of Radiology , Royal College Of Surgeons In Ireland in 2007. In 2010 he got CCST 'completion of certified specialist training certificate’ from Faculty of Radiology, The Royal College Of Surgeons In Ireland and entry in to specialist register in Medical Council of Ireland. In Tawam in early 2011, Dr. Mansoor successfully led the commissioning and clinical use of the HiArt TomoTherapy system with IMRT & IGRT, one and only in UAE. . In 2013 Dr. Mansoor chaired RapidArc committee, making sure smooth and swift implementation of RapidArc technology with IMRT & IGRT capability in Tawam. In 2015 Dr. Mansoor was appointed as Adjunct Assistant Professor in College of Medicine and health Sciences in UAE University. . In 2018 as lead radiation oncologist, he successfully led the QUATRO certification of the radiotherapy department by IAEA. He is clinical lead Radiation oncologist for Lymphoma, Sarcoma, Urology & GI tumours. "

Dr. Hani Osman

Consultant Oncologist | United Arab Emirates

"Dr. Hani Yousif Osman graduated from the Faculty of the Medicine University of Khartoum Sudan. He moved to the United Kingdom where he completed his training in internal medicine and obtained his MRCP (UK) degree, Fellowship from the Royal college of pathologists and CCT. He completed his high specialist training in hematology at the University of Cardiff hospital UK. His research focuses on acute myeloid leukemia novel therapy, He has extensive hematology consultant experience in the UK, Saudia Arabia, and the United Arab Emirates. Dr. Osman was involved and the principle investigator for many clinical trials and he has over 30 publications.

Prof. Giovanni Martinelli

Associate Professor | Italy

Prof. Giovanni Martinelli Scientific Director Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl – IRCCS - Italy. His research and clinical activity involve the area of acute and chronic myeloid leukemia (AML and CML), acute lymphoblastic leukemia (ALL) and myelodisplastic syndromes (MDS). His expertise is in Conduction of several Phase I-II-III clinical trials and biological research projects on AML, ALL, MDS and CML as Principal Investigator, with good knowledge of Good Clinical Practice. He has the skills, expertise and authority to lead a team and he has the capacity of using the resources in a flexible way, to achieve the project objectives.

Prof. Mahmoud Marashi

Consultant Haematologist | United Arab Emirates

"Prof. Mahmoud Marashi joined Mediclinic City Hospital as Consultant Haematologist with over 30 years experience in haematology. He established the clinical haematology service in Dubai Health Authority which is involved in the management of both benign disorders (anaemias, bleeding disorders, thrombosis/thrombophilia) and malignant disorders (acute and chronic leukaemias, myeloma, myeloproliferative disorders, myelodysplastic syndrome). He runs both an undergraduate and postgraduate training in Haematology. Prof. Marashi did his undergraduate training in Andhra University, India. His haematology training was done in the UL at Heartlands Hospital, Birmingham, (formerly East Birmingham Hospital), The West Midlands Blood Transfusion Service, Edgbaston, Birmingham, The John Radcliffe Hospital and Chuchill Hospital in Oxford, UK. Prof. Marashi has been involved in medical education for over 20 years. He is a Professor of Medicine and Haematology and is the Head of the Academic Department of Medicine, Dubai Medical College / Dubai Health Authority. He is also an external examiner for the Royal College of Physicians of UK. *Independent Doctors (ID): Defined as individuals not employed by Mediclinic Middle East who are granted the privilege to treat patient at MCME facilities, in either inpatient or outpatient settings, as applicable."

Dr. Arif Raza Alam

Chief of Hematology | United Arab Emirates

Chief of Hematology – Tawam Hospital

Prof. Giovanni Martinelli

Associate Professor | Italy

Prof. Giovanni Martinelli Scientific Director Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl – IRCCS - Italy. His research and clinical activity involve the area of acute and chronic myeloid leukemia (AML and CML), acute lymphoblastic leukemia (ALL) and myelodisplastic syndromes (MDS). His expertise is in Conduction of several Phase I-II-III clinical trials and biological research projects on AML, ALL, MDS and CML as Principal Investigator, with good knowledge of Good Clinical Practice. He has the skills, expertise and authority to lead a team and he has the capacity of using the resources in a flexible way, to achieve the project objectives.

Dr. Hani Osman

Consultant Oncologist | United Arab Emirates

"Dr. Hani Yousif Osman graduated from the Faculty of the Medicine University of Khartoum Sudan. He moved to the United Kingdom where he completed his training in internal medicine and obtained his MRCP (UK) degree, Fellowship from the Royal college of pathologists and CCT. He completed his high specialist training in hematology at the University of Cardiff hospital UK. His research focuses on acute myeloid leukemia novel therapy, He has extensive hematology consultant experience in the UK, Saudia Arabia, and the United Arab Emirates. Dr. Osman was involved and the principle investigator for many clinical trials and he has over 30 publications.

Dr. Hani Osman

Consultant Oncologist | United Arab Emirates

"Dr. Hani Yousif Osman graduated from the Faculty of the Medicine University of Khartoum Sudan. He moved to the United Kingdom where he completed his training in internal medicine and obtained his MRCP (UK) degree, Fellowship from the Royal college of pathologists and CCT. He completed his high specialist training in hematology at the University of Cardiff hospital UK. His research focuses on acute myeloid leukemia novel therapy, He has extensive hematology consultant experience in the UK, Saudia Arabia, and the United Arab Emirates. Dr. Osman was involved and the principle investigator for many clinical trials and he has over 30 publications.

Prof. Mahmoud Marashi

Consultant Haematologist | United Arab Emirates

"Prof. Mahmoud Marashi joined Mediclinic City Hospital as Consultant Haematologist with over 30 years experience in haematology. He established the clinical haematology service in Dubai Health Authority which is involved in the management of both benign disorders (anaemias, bleeding disorders, thrombosis/thrombophilia) and malignant disorders (acute and chronic leukaemias, myeloma, myeloproliferative disorders, myelodysplastic syndrome). He runs both an undergraduate and postgraduate training in Haematology. Prof. Marashi did his undergraduate training in Andhra University, India. His haematology training was done in the UL at Heartlands Hospital, Birmingham, (formerly East Birmingham Hospital), The West Midlands Blood Transfusion Service, Edgbaston, Birmingham, The John Radcliffe Hospital and Chuchill Hospital in Oxford, UK. Prof. Marashi has been involved in medical education for over 20 years. He is a Professor of Medicine and Haematology and is the Head of the Academic Department of Medicine, Dubai Medical College / Dubai Health Authority. He is also an external examiner for the Royal College of Physicians of UK. *Independent Doctors (ID): Defined as individuals not employed by Mediclinic Middle East who are granted the privilege to treat patient at MCME facilities, in either inpatient or outpatient settings, as applicable."

Dr. Faraz Khan

Head Of Hematology Program | United Arab Emirates

Asst Prof Dr. Faraz Khan is a Consultant Hematologist and Medical Oncologist with over 15 years experience in treating cancer and various blood diseases. He completed his Internal Medicine, Hematology and Medical oncology training from the University of Connecticut, CT, USA and is triple board certified in Internal medicine, Hematology and Medical Oncology. He worked as a consultant Hematologist/Medical Oncologist at PEI Cancer Treatment Center, PE, Canada and directed the provincial hemophilia and bleeding disorder clinic.

Dr. Shahrukh Hashmi

Chairman | United Arab Emirates

"Dr. Shahrukh Hashmi is the acting Dean of Research at SSMC, Abu Dhabi, UAE. He graduated from Baqai Medical University, Pakistan, as the top graduate receiving Gold Medal from the President of Pakistan. He received Master’s Degree (MPH) from Yale University, Connecticut, USA. He is a Diplomat of the American Board of Preventive Medicine/Public Health, Internal Medicine, and Hematology. He has been at Mayo Clinic, Minnesota, USA for >10 years. He started Mayo Clinic’s first BMT survivorship program. He has served as PI or Co-PI on many industry-sponsored and NIH sponsored trials. His research interests include premature aging, artificial intelligence, and GVHD. He is also involved in Stem Cell Therapeutics particularly in regenerative hematology. He has authored >220 articles in peer-reviewed journals, including in JAMA, Lancet, and in NEJM. He chairs many national or international professional committees/groups including being the chair of the Worldwide Network for Blood and Marrow Transplant’s Nuclear Accident committee (Geneva, Switzerland), founding chair of American Society for Blood and Marrow Transplant Society’s Survivorship SIG (Chicago, Illinois), and co-chair of the Center for International Blood & Marrow Transplant Registry’s (CIBMTR) Health Services Committee (Milwaukee, Wisconsin). He is currently the chairperson of the Dept. of Hematology/Oncology at the SSMC, Abu Dhabi, UAE, and the chairperson of SEHA Oncology Council. He is also faculty at Khalifa University, UAE, and adjunct faculty at Mohamad Bin Zayed University of Artificial Intelligence, UAE."

Dr. Syed Mansoor Hasnain

Consultant Radiation Oncologist | United Arab Emirates

"Dr. Syed Mansoor Hasnain is working in Tawam Hospital, Alain, UAE as Consultant Radiation Oncologist. He joined Tawam Hospital in 2009. He initially trained as surgeon and did fellowship in surgery ,FRCS(Glasg) from Royal College Of Physicians and Surgeons Of Glasgow in 2000. In 2001 he started his career and specialist registrar Training in radiation Oncology under supervision of Faculty of Radiology, The Royal College Of Surgeons In Ireland in Saint Luke’s Hospital. He passed FRCR part 1 from Royal College of Radiologists, London U.K. He did fellowship in radiotherapy ‘FFR RCSI’ from Faculty of Radiology , Royal College Of Surgeons In Ireland in 2007. In 2010 he got CCST 'completion of certified specialist training certificate’ from Faculty of Radiology, The Royal College Of Surgeons In Ireland and entry in to specialist register in Medical Council of Ireland. In Tawam in early 2011, Dr. Mansoor successfully led the commissioning and clinical use of the HiArt TomoTherapy system with IMRT & IGRT, one and only in UAE. . In 2013 Dr. Mansoor chaired RapidArc committee, making sure smooth and swift implementation of RapidArc technology with IMRT & IGRT capability in Tawam. In 2015 Dr. Mansoor was appointed as Adjunct Assistant Professor in College of Medicine and health Sciences in UAE University. . In 2018 as lead radiation oncologist, he successfully led the QUATRO certification of the radiotherapy department by IAEA. He is clinical lead Radiation oncologist for Lymphoma, Sarcoma, Urology & GI tumours. "

Prof. Giovanni Martinelli

Associate Professor | Italy

Prof. Giovanni Martinelli Scientific Director Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl – IRCCS - Italy. His research and clinical activity involve the area of acute and chronic myeloid leukemia (AML and CML), acute lymphoblastic leukemia (ALL) and myelodisplastic syndromes (MDS). His expertise is in Conduction of several Phase I-II-III clinical trials and biological research projects on AML, ALL, MDS and CML as Principal Investigator, with good knowledge of Good Clinical Practice. He has the skills, expertise and authority to lead a team and he has the capacity of using the resources in a flexible way, to achieve the project objectives.

Dr. Amar Lal

Hematologist and Oncologist | United Arab Emirates

"Dr. Amar Lal graduated from Dow University in 1993. He underwent medicine residency and followed by oncology fellowship. He qualified triple diploma in medicine, family medicine and oncology from CPSP Pakistan. Then he got triple diplomas from Royal Colleges of Physicians Ireland and Glasgow in medicine and speciality certificates oncology royal college London. He also qualified ESMO Examination Board in oncology. He has been local and international speaker in hematology and oncology and has more than 40 publications. He joined Tawam hospital in 2007 and he continued to be an active part of CME/ Scientific Program Coordinator, Member of Pharmacy & Therapeutics Committee (PTC), Patient safety physician manager, Member of Medication Utilization Committee (MSSC). "

Dr. Arif Raza Alam

Chief of Hematology | United Arab Emirates

Chief of Hematology – Tawam Hospital

Dr. Muhammad Zafar Javed

Chief of Palliative Care Clinics | United Arab Emirates

Chief of Palliative Care Clinics – Tawam Hospital

Dr. Justin Sanders

Associate Professor of Family Medicine | Canada

Dr. Justin Sanders is the Kappy and Eric M. Flanders Chair of Palliative Care, Director of Palliative Care, and Associate Professor of Family Medicine at McGill University. Dr. Sanders qualitative and mixed-methods research focuses on cross-cultural serious illness communication and authentic healing relationships in order to drive quality and equity in the care of those affected by advanced cancer and other serious illnesses. Dr. Sanders completed fellowship training in Palliative Care at Massachusetts General Hospital and the Dana-Farber Cancer Institute in 2014, where he remained on the faculty at Harvard Medical School until 2021. As an associate faculty member at Ariadne Labs, a health systems innovation center at the Brigham and Women's Hospital and the Harvard T.H. Chan School of Public Health, Dr. Sanders continues to work on system level approaches to improving serious illness communication and care.

Dr. Amna AlHarrasi

Palliative Care and Cancer pain Consultant | Oman

Dr Amna Ahmed Al Harrasi, a Palliative Care and Cancer pain Consultant at Sultan Qaboos Comprehensive Cancer care and research center since September 2021. Dr Amna’s Educational background started with MD degree obtained from Sultan Qaboos University in 2010 followed by Postgraduate Residency in Family medicine from Oman Medical Specialty Board in 2015. Dr Amna developed special interest in the field of palliative care and pursued further qualification in Palliative care residency from McGill University from 2018-2019 followed by advanced study of Cancer pain fellowship from McGill University as well in 2019-2020. She worked in the field of primary care as family physician from 2015-2018. Dr Amna’s current clinical work is focused on palliative care and cancer pain management at Sultan Qaboos Comprehensive care and research center (2021-2022). Her initial research interest was general medicine and primary care. Her current interests are palliative care especially in gastrointestinal malignancies and cancer pain research. Dr Amna is a member of many international medical Societies including MASCC, EFIC, NCCN, ESMO and ASCO.

Dr. Katie Sweeting

Specialist Palliative Care | United Arab Emirates

Dr. Katie completed specialist training in London and South East England to become a consultant in palliative medicine in 2009, working in both acute hospital and hospice settings. She has extensive experience of managing symptoms, concerns and expectations of patients with advanced cancer and other life-limiting illnesses. She is accredited by the Royal College of Physicians (UK) as both an educational supervisor and mentor.

Dr. Mona Tareen

Consultant in Palliative, Geriatric and Internal Medicine | United Arab Emirates

Dr. Mona Tareen is a Consultant in Palliative, Geriatric and Internal Medicine. She obtained her basic medical degree from Dhow Medical College, Karachi, Pakistan and completed her US Board Certification in Internal Medicine, Geriatrics Board Certification and Hospice and Palliative Medicine. She has worked as Palliative Medicine Consultant and Medical Director of Hospice and Palliative Care Program in the US and also served the Rush University Medical Center, Chicago, as Consultant Geriatrician.

Dr. Justin Sanders

Associate Professor of Family Medicine | Canada

Dr. Justin Sanders is the Kappy and Eric M. Flanders Chair of Palliative Care, Director of Palliative Care, and Associate Professor of Family Medicine at McGill University. Dr. Sanders qualitative and mixed-methods research focuses on cross-cultural serious illness communication and authentic healing relationships in order to drive quality and equity in the care of those affected by advanced cancer and other serious illnesses. Dr. Sanders completed fellowship training in Palliative Care at Massachusetts General Hospital and the Dana-Farber Cancer Institute in 2014, where he remained on the faculty at Harvard Medical School until 2021. As an associate faculty member at Ariadne Labs, a health systems innovation center at the Brigham and Women's Hospital and the Harvard T.H. Chan School of Public Health, Dr. Sanders continues to work on system level approaches to improving serious illness communication and care.

Dr. Amna AlHarrasi

Palliative Care and Cancer pain Consultant | Oman

Dr Amna Ahmed Al Harrasi, a Palliative Care and Cancer pain Consultant at Sultan Qaboos Comprehensive Cancer care and research center since September 2021. Dr Amna’s Educational background started with MD degree obtained from Sultan Qaboos University in 2010 followed by Postgraduate Residency in Family medicine from Oman Medical Specialty Board in 2015. Dr Amna developed special interest in the field of palliative care and pursued further qualification in Palliative care residency from McGill University from 2018-2019 followed by advanced study of Cancer pain fellowship from McGill University as well in 2019-2020. She worked in the field of primary care as family physician from 2015-2018. Dr Amna’s current clinical work is focused on palliative care and cancer pain management at Sultan Qaboos Comprehensive care and research center (2021-2022). Her initial research interest was general medicine and primary care. Her current interests are palliative care especially in gastrointestinal malignancies and cancer pain research. Dr Amna is a member of many international medical Societies including MASCC, EFIC, NCCN, ESMO and ASCO.

Dr. Katie Sweeting

Specialist Palliative Care | United Arab Emirates

Dr. Katie completed specialist training in London and South East England to become a consultant in palliative medicine in 2009, working in both acute hospital and hospice settings. She has extensive experience of managing symptoms, concerns and expectations of patients with advanced cancer and other life-limiting illnesses. She is accredited by the Royal College of Physicians (UK) as both an educational supervisor and mentor.

Dr. Nandan Shanbagh

Specialist in Radiation Oncology and Palliative Care | United Arab Emirates

Dr Nandan Shanbhag is a specialist in Radiation Oncology and Palliative Care. After completing his Bachelor’s in Medicine and Surgery (MBBS) and Post Graduate degree in Radiation Oncology from India, he completed his diploma in Palliative Medicine at the University of Cape Town in South Africa. He has worked in several countries across the world and helped establish cancer departments in India, Botswana, Bahrain and Antigua and Barbuda. He holds special research interest in application of Machine Learning in Oncology and Palliative care. He also completed his Executive Masters in Business Administration and remains an active member at various societies related to Oncology.

Dr. Muhammad Zafar Javed

Chief of Palliative Care Clinics | United Arab Emirates

Chief of Palliative Care Clinics – Tawam Hospital

Dr. Majed Al Ghamdi

Assistant Professor and Consultant Radiation Oncologist | Saudi Arabia

Dr. Alghamdi, MD, MBA, FRCPC, DABR is an assistant professor and consultant radiation oncologist with a sub-specialization in treating central nervous system (CNS) tumors and stereotactic radiosurgery. He completed his residency training at university of Calgary, Alberta, Canada in 2016 and his fellowship training at university of Toronto, Ontario, Canada in 2017. He holds Canadian and American boards in radiation oncology. He has published three textbook chapters and numerous peer-reviewed manuscripts that mainly focused on CNS oncology. Recently, Dr. Alghamdi completed masters degree in business administration from prince Mohammad Bin Salman College of Business and Entrepreneurship.

Dr. Paul Kelly

Consultant Radiation Oncologist | Ireland

Dr Paul Kelly is a graduate of University College Cork and completed General Professional Training in medicine at the Mater Hospital, Dublin. Having acquired Membership of the Royal College of Physicians he completed specialist training in Radiation Oncology at St Luke’s Hospital in Dublin. He became a Fellow of the Faculty of Radiology at the Royal College of Surgeons in Ireland in 2008 and, thereafter, completed a 2-year Clinical Fellowship in Stereotactic Radiosurgery at Brigham and Women’s Hospital/Dana-Farber Cancer Institute in Boston, Massachusetts. Based in Cork since 2011 as a Consultant Radiation Oncologist he is active in clinical research and co-chairs the GU disease-specific subgroup (DSSG) of Cancer Trials Ireland. His chief interests include prostate cancer, brain tumours, stereotactic radiotherapy and prostate seed brachytherapy. He took up a position as Medical Director of the new radiation oncology facility at the Bon Secours Radiotherapy Centre joint venture with University of Pittsburgh Medical Centre (UPMC) Hillman Cancer Centre in 2019.

Dr. Nadeem Pervez

Radiation Oncologist | Oman

"Dr. Nadeem Pervez qualified in Radiation Oncologist from Ireland and Canada. He worked in Ireland, Canada and Middle East at various academic levels. He served as radiation oncologist at Cross Cancer Institute and Associate Professor at University of Alberta, Edmonton, Alberta, Canada. His clinical work includes treating cancer of various sites with emphasis on breast and prostate cancer. He was a prominent member of Prostate Cancer Brachytherapy seed implantation treatment in Canada. He is initiating Prostate Brachytherapy treatment in the Middle East. He co-chaired breast cancer group in Alberta and contributed to Alberta Breast Cancer Treatment guidelines. He was involved in invention of newer radiotherapy machines. Nadeem was actively involved in contributing to Resident Training program and Clinical Research Fellowship program in Radiation Oncology at the University of Alberta, Canada. He was awarded best teacher award from residents to acknowledge his contributions. He oversees research projects from international fellows. His residents and fellows later appointed at key academic, clinical and leadership positions across world. He was invited as scientific speaker in multiple countries. Nadeem is actively involved in clinical research. He was able to secure multiple competitive research grants from awarding agencies. He was leading investigator initiated studies and involved in multi-institutional cooperative group studies. He published multiple research articles in reputed journals. He served in institutional ethics committees, research funds granting agencies, medical student selection committees, oncology conference scientific committee and peer-reviewed several Oncology journals. He is founding member in establishing Middle East Society of Therapeutic Radiation Oncology (MESTRO). "

Dr. Rana Mahmood

Consultant Oncologist | United Arab Emirates

Dr Rana Mahmood trained in UK and has been a consultant in oncology for last 15 years. Dr Mahmood has special interest in advance image guided radiotherapy, SABR and image based High Dose rate Brachytherapy. He is the first to introduce and only practitioner to provide Gynaecological interstitial brachytherapy in UAE. He has setup the only service in UAE to provide prostate Brachytherapy and trans-perineal spacer device. He has been principal investigator for several landmark radiotherapy trials and extensively published his work.

Dr. Rana Mahmood

Consultant Oncologist | United Arab Emirates

Dr Rana Mahmood trained in UK and has been a consultant in oncology for last 15 years. Dr Mahmood has special interest in advance image guided radiotherapy, SABR and image based High Dose rate Brachytherapy. He is the first to introduce and only practitioner to provide Gynaecological interstitial brachytherapy in UAE. He has setup the only service in UAE to provide prostate Brachytherapy and trans-perineal spacer device. He has been principal investigator for several landmark radiotherapy trials and extensively published his work.

Dr. Fady Geara

Department Chair of Radiation Oncology | United Arab Emirates

"Dr. Fady Geara MD, PhD, is Department Chair of Radiation Oncology at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Geara served as Professor and Chairman of Radiation Oncology at the American University of Beirut Medical Center, Lebanon, after having been recruited from the University of Texas MD Anderson Cancer Center in Houston, Texas, US. Dr. Geara received his medical degree from the University of Paris XI, France, and completed his residency and fellowship at the University of Texas MD Anderson Cancer Center in Houston, Texas, US. Throughout his tenure, Dr. Geara has developed many state-of-the-art radiation oncology procedures. He developed the first high dose rate brachytherapy program in the Middle East, as well as the first Stereotactic Radiosurgery program. Over the years, Dr. Geara has become established as both a regional and international leader within his specialty. "

Dr. Majed Al Ghamdi

Assistant Professor and Consultant Radiation Oncologist | Saudi Arabia

Dr. Alghamdi, MD, MBA, FRCPC, DABR is an assistant professor and consultant radiation oncologist with a sub-specialization in treating central nervous system (CNS) tumors and stereotactic radiosurgery. He completed his residency training at university of Calgary, Alberta, Canada in 2016 and his fellowship training at university of Toronto, Ontario, Canada in 2017. He holds Canadian and American boards in radiation oncology. He has published three textbook chapters and numerous peer-reviewed manuscripts that mainly focused on CNS oncology. Recently, Dr. Alghamdi completed masters degree in business administration from prince Mohammad Bin Salman College of Business and Entrepreneurship.

Dr. Nadeem Pervez

Radiation Oncologist | Oman

"Dr. Nadeem Pervez qualified in Radiation Oncologist from Ireland and Canada. He worked in Ireland, Canada and Middle East at various academic levels. He served as radiation oncologist at Cross Cancer Institute and Associate Professor at University of Alberta, Edmonton, Alberta, Canada. His clinical work includes treating cancer of various sites with emphasis on breast and prostate cancer. He was a prominent member of Prostate Cancer Brachytherapy seed implantation treatment in Canada. He is initiating Prostate Brachytherapy treatment in the Middle East. He co-chaired breast cancer group in Alberta and contributed to Alberta Breast Cancer Treatment guidelines. He was involved in invention of newer radiotherapy machines. Nadeem was actively involved in contributing to Resident Training program and Clinical Research Fellowship program in Radiation Oncology at the University of Alberta, Canada. He was awarded best teacher award from residents to acknowledge his contributions. He oversees research projects from international fellows. His residents and fellows later appointed at key academic, clinical and leadership positions across world. He was invited as scientific speaker in multiple countries. Nadeem is actively involved in clinical research. He was able to secure multiple competitive research grants from awarding agencies. He was leading investigator initiated studies and involved in multi-institutional cooperative group studies. He published multiple research articles in reputed journals. He served in institutional ethics committees, research funds granting agencies, medical student selection committees, oncology conference scientific committee and peer-reviewed several Oncology journals. He is founding member in establishing Middle East Society of Therapeutic Radiation Oncology (MESTRO). "

Dr. Paul Kelly

Consultant Radiation Oncologist | Ireland

Dr Paul Kelly is a graduate of University College Cork and completed General Professional Training in medicine at the Mater Hospital, Dublin. Having acquired Membership of the Royal College of Physicians he completed specialist training in Radiation Oncology at St Luke’s Hospital in Dublin. He became a Fellow of the Faculty of Radiology at the Royal College of Surgeons in Ireland in 2008 and, thereafter, completed a 2-year Clinical Fellowship in Stereotactic Radiosurgery at Brigham and Women’s Hospital/Dana-Farber Cancer Institute in Boston, Massachusetts. Based in Cork since 2011 as a Consultant Radiation Oncologist he is active in clinical research and co-chairs the GU disease-specific subgroup (DSSG) of Cancer Trials Ireland. His chief interests include prostate cancer, brain tumours, stereotactic radiotherapy and prostate seed brachytherapy. He took up a position as Medical Director of the new radiation oncology facility at the Bon Secours Radiotherapy Centre joint venture with University of Pittsburgh Medical Centre (UPMC) Hillman Cancer Centre in 2019.

Dr. Abdulrahman Sulaiman Bin Sumaida

Chief of Radiotherapy | United Arab Emirates

Chief of Radiotherapy - Tawam Hospital

Dr. Mohammad Asha

Consultant Physician, Neurosurgery Clinics | United Arab Emirates

Consultant Physician, Neurosurgery Clinics Tawam Hospital

Dr. Paul Sanghera

Clinical oncology consultant and honorary lecturer | United Kingdom

Following clinical oncology training in London and Birmingham, Paul undertook a brain tumour fellowship with The University of Toronto. Paul returned to The UK in 2008 and was appointed a clinical oncologist at University Hospitals Birmingham. Paul has had a busy clinical Neuro-Oncology practice since this appointment. He led the radiotherapy department between 2013 and 2018, and then the neuro-oncology tumour board from 2018. Paul is the current regional brain tumour research lead and expert advisory group chair. Paul has been an investigator on several brain tumour studies, served on trial management groups, published widely and supported national research groups working to develop new clinical trials

Dr. Majed Al Ghamdi

Assistant Professor and Consultant Radiation Oncologist | Saudi Arabia

Dr. Alghamdi, MD, MBA, FRCPC, DABR is an assistant professor and consultant radiation oncologist with a sub-specialization in treating central nervous system (CNS) tumors and stereotactic radiosurgery. He completed his residency training at university of Calgary, Alberta, Canada in 2016 and his fellowship training at university of Toronto, Ontario, Canada in 2017. He holds Canadian and American boards in radiation oncology. He has published three textbook chapters and numerous peer-reviewed manuscripts that mainly focused on CNS oncology. Recently, Dr. Alghamdi completed masters degree in business administration from prince Mohammad Bin Salman College of Business and Entrepreneurship.

Dr. Gelareh Zadeh

Professor | Canada

"Dr Gelareh Zadeh is a Professor at the Department of Surgery University of Toronto. She is a Neurosurgeon-Scientist at Toronto Western Hospital, University Health Network. She was most recently appointed as the Wilkins Family Chair in Brain Tumor Research. Her clinical practice focuses on Skull Base Neuro-oncology, with dedicated general brain tumour clinic and many multidisciplinary clinics that she has established and is actively involved with such as skull base, pituitary, brain metastases, gamma knife and neurofibromatosis clinic. She is actively involved with and is dedicated to the goal of advancing surgical clinical trials. Her research laboratory is focused on studying the molecular mechanisms of glioma angiogenesis and molecular regulators of tumour metabolism. Specifically investigating the role of bone marrow derived cells in supporting tumour vasculature in gliomas and how differentiation into macrophage and microglia population plays a role in escape mechanisms of evading anti-angiogenic therapy. A second focus of the laboratory, on tumour metabolism, explores the interplay between altered metabolism in response to anti-angiogenic therapy. She also has a translational program, dedicated to establishing the genomic landscape of menigniomas and schwannomas. Her laboratory is funded through peer-reviewed grants from a number of agencies such as CIHR, Terry Fox New Investigator grant, CCSRI, CRS, BrainChild and others. She is a scientist at Labatts Brain Tumor Research at Sick Kids Research Institute and Macfeeters-Hamilton Neuro-oncology Centre at Ontario Cancer Institute. She is active in many local, national and international committees in the field of neuro-oncology. She is the director of the UHN brain tumor bank and co-director of the University of Toronto Brain Tumor Bank. Together with Dr Vera Bril she is the co-Director of the UHN Elizabeth Raab Neurofibromatosis Program. She is the Chair of Academic Affairs for Division of Neurosurgery at University of Toronto. She has served as the scientific co-chair of Society of Neuro-oncology for two years (2014 and 2015), she is currently the Secretary/Treasurer of Society of Neuro-oncology (2016 & 17) and Chairof Neuro-oncology Committee at the World Federation of Neurological Surgeons (2013-17). She is the co-chair and founder of the consortium on meningiomas, in collaboration with Society of Neuro-oncology."

Dr. Syed Zubair

Consultant Medical Oncologist | Saudi Arabia

He is a Consultant Medical Oncologist at the King Faisal Specialist Hospital and Research Centre in Jeddah and have specialist interest in the management of colorectal, prostate and CNS tumors.He completed his post graduate medical education in the UK and trained as a medical Oncologist at the Yorkshire Deanery leading to a CCT in Medical Oncology. he initially worked as a Consultant Medical Oncologist at St James University Hospital in Leeds and then spent nearly a decade at the James Cook University Hospital in the North East of UK prior to moving to Jeddah. He has been involved in recruiting many patients to various phase 2 and phase 3 clinical trials during my career and currently the chairman of the Oncology Mortality and Morbidity committee at KFSHRC in Jeddah

Dr. Aly Abdel Razek

Chairman and Executive Director | United Arab Emirates

Dr. Abdel Razek graduated from Cairo University. He completed his residency in 1976 at Washington University in St. Louis, Mo., USA. He is board certified in both Radiation Oncology and Pediatrics. He co-authored four text books in radiation oncology and contributed to many publications in oncology journals. He served on the national committee of the Southwest Oncology Group, Intergroup Ewings Sarcoma and National Wilms Tumor Committee. Dr. Abdel Razek is a Fellow of the American College of Radiation Oncology. He is president of Medical Resources International and Chairman and Executive Director of the Gulf International Cancer Center.

Dr. Gelareh Zadeh

Professor | Canada

"Dr Gelareh Zadeh is a Professor at the Department of Surgery University of Toronto. She is a Neurosurgeon-Scientist at Toronto Western Hospital, University Health Network. She was most recently appointed as the Wilkins Family Chair in Brain Tumor Research. Her clinical practice focuses on Skull Base Neuro-oncology, with dedicated general brain tumour clinic and many multidisciplinary clinics that she has established and is actively involved with such as skull base, pituitary, brain metastases, gamma knife and neurofibromatosis clinic. She is actively involved with and is dedicated to the goal of advancing surgical clinical trials. Her research laboratory is focused on studying the molecular mechanisms of glioma angiogenesis and molecular regulators of tumour metabolism. Specifically investigating the role of bone marrow derived cells in supporting tumour vasculature in gliomas and how differentiation into macrophage and microglia population plays a role in escape mechanisms of evading anti-angiogenic therapy. A second focus of the laboratory, on tumour metabolism, explores the interplay between altered metabolism in response to anti-angiogenic therapy. She also has a translational program, dedicated to establishing the genomic landscape of menigniomas and schwannomas. Her laboratory is funded through peer-reviewed grants from a number of agencies such as CIHR, Terry Fox New Investigator grant, CCSRI, CRS, BrainChild and others. She is a scientist at Labatts Brain Tumor Research at Sick Kids Research Institute and Macfeeters-Hamilton Neuro-oncology Centre at Ontario Cancer Institute. She is active in many local, national and international committees in the field of neuro-oncology. She is the director of the UHN brain tumor bank and co-director of the University of Toronto Brain Tumor Bank. Together with Dr Vera Bril she is the co-Director of the UHN Elizabeth Raab Neurofibromatosis Program. She is the Chair of Academic Affairs for Division of Neurosurgery at University of Toronto. She has served as the scientific co-chair of Society of Neuro-oncology for two years (2014 and 2015), she is currently the Secretary/Treasurer of Society of Neuro-oncology (2016 & 17) and Chairof Neuro-oncology Committee at the World Federation of Neurological Surgeons (2013-17). She is the co-chair and founder of the consortium on meningiomas, in collaboration with Society of Neuro-oncology."

Dr. Paul Sanghera

Clinical oncology consultant and honorary lecturer | United Kingdom

Following clinical oncology training in London and Birmingham, Paul undertook a brain tumour fellowship with The University of Toronto. Paul returned to The UK in 2008 and was appointed a clinical oncologist at University Hospitals Birmingham. Paul has had a busy clinical Neuro-Oncology practice since this appointment. He led the radiotherapy department between 2013 and 2018, and then the neuro-oncology tumour board from 2018. Paul is the current regional brain tumour research lead and expert advisory group chair. Paul has been an investigator on several brain tumour studies, served on trial management groups, published widely and supported national research groups working to develop new clinical trials

Dr. Majed Al Ghamdi

Assistant Professor and Consultant Radiation Oncologist | Saudi Arabia

Dr. Alghamdi, MD, MBA, FRCPC, DABR is an assistant professor and consultant radiation oncologist with a sub-specialization in treating central nervous system (CNS) tumors and stereotactic radiosurgery. He completed his residency training at university of Calgary, Alberta, Canada in 2016 and his fellowship training at university of Toronto, Ontario, Canada in 2017. He holds Canadian and American boards in radiation oncology. He has published three textbook chapters and numerous peer-reviewed manuscripts that mainly focused on CNS oncology. Recently, Dr. Alghamdi completed masters degree in business administration from prince Mohammad Bin Salman College of Business and Entrepreneurship.

Dr. Syed Zubair

Consultant Medical Oncologist | Saudi Arabia

He is a Consultant Medical Oncologist at the King Faisal Specialist Hospital and Research Centre in Jeddah and have specialist interest in the management of colorectal, prostate and CNS tumors.He completed his post graduate medical education in the UK and trained as a medical Oncologist at the Yorkshire Deanery leading to a CCT in Medical Oncology. he initially worked as a Consultant Medical Oncologist at St James University Hospital in Leeds and then spent nearly a decade at the James Cook University Hospital in the North East of UK prior to moving to Jeddah. He has been involved in recruiting many patients to various phase 2 and phase 3 clinical trials during my career and currently the chairman of the Oncology Mortality and Morbidity committee at KFSHRC in Jeddah

Dr. Mohammad Asha

Consultant Physician, Neurosurgery Clinics | United Arab Emirates

Consultant Physician, Neurosurgery Clinics Tawam Hospital

Dr. Selvaraj Giridharan

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr Selvaraj Giridharan is a highly skilled and experienced oncologist with dual accreditation from the UK. He completed his Bachelor’s Medical degree from the University of Madras in 1993 and went on to continue his training in the UK, he became a member of Royal college of Physicians in 1998 and then achieved clinical oncology Fellowship in 2004. He worked as a consultant clinical oncologist in University Hospitals of North Midlands from 2004 to 2022 until his appointment to Tawam Hospitals in September this year. During his time in Stoke he held several additional roles including being services lead, audit lead, research lead, appraiser and clinical tutor. He has published extensively and has been a PI and SI for more than 30 clinical trials.